In the News

FDA Approves US WorldMeds' MYOBLOC® (rimabotulinumtoxinB) Injection for Chronic Sialorrhea

August 2019

Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

August 2019

APDA Research Symposium

April 2019

Link to Symposium website  

EvergreenHealth Neurologist and Parkinson's expert Dr. Pinky Agarwal participated in the researcher panel: